Technology & Policy

DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme

Isharwal, S., D.V. Makarov, H.B. Carter,J.I. Epstein, A.W. Partin, P. Landis, C. Marlow, and R.W. Veltri
DNA content in the diagnostic biopsy for benign-adjacent and cancer-tissue areas predicts the need for treatment in men with T1c prostate cancer undergoing surveillance in an expectant management programme ">Read more

Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score

Huang, Y., S. Isharwal, A. Haese, F.K.H. Chun,D.V. Makarov, Z. Feng, M. Han, E. Humphreys, J.I. Epstein, A.W. Partin, and R.W. Veltri
Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score ">Read more